BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 18569015)

  • 1. Quinone and oxyradical scavenging properties of N-acetylcysteine prevent dopamine mediated inhibition of Na+, K+-ATPase and mitochondrial electron transport chain activity in rat brain: implications in the neuroprotective therapy of Parkinson's disease.
    Bagh MB; Maiti AK; Jana S; Banerjee K; Roy A; Chakrabarti S
    Free Radic Res; 2008 Jun; 42(6):574-81. PubMed ID: 18569015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of rat brain mitochondrial electron transport chain activity by dopamine oxidation products during extended in vitro incubation: implications for Parkinson's disease.
    Khan FH; Sen T; Maiti AK; Jana S; Chatterjee U; Chakrabarti S
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):65-74. PubMed ID: 15925494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine oxidation products inhibit Na+, K+-ATPase activity in crude synaptosomal-mitochondrial fraction from rat brain.
    Khan FH; Sen T; Chakrabarti S
    Free Radic Res; 2003 Jun; 37(6):597-601. PubMed ID: 12868486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction mediated by quinone oxidation products of dopamine: Implications in dopamine cytotoxicity and pathogenesis of Parkinson's disease.
    Jana S; Sinha M; Chanda D; Roy T; Banerjee K; Munshi S; Patro BS; Chakrabarti S
    Biochim Biophys Acta; 2011 Jun; 1812(6):663-73. PubMed ID: 21377526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine but not 3,4-dihydroxy phenylacetic acid (DOPAC) inhibits brain respiratory chain activity by autoxidation and mitochondria catalyzed oxidation to quinone products: implications in Parkinson's disease.
    Jana S; Maiti AK; Bagh MB; Banerjee K; Das A; Roy A; Chakrabarti S
    Brain Res; 2007 Mar; 1139():195-200. PubMed ID: 17291463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary supplementation with N-acetylcysteine, alpha-tocopherol and alpha-lipoic acid prevents age related decline in Na(+),K (+)-ATPase activity and associated peroxidative damage in rat brain synaptosomes.
    Bagh MB; Maiti AK; Roy A; Chakrabarti S
    Biogerontology; 2008 Dec; 9(6):421-8. PubMed ID: 18787974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain mitochondria catalyze the oxidation of 7-(2-aminoethyl)-3,4-dihydro-5-hydroxy-2H-1,4-benzothiazine-3-carboxyli c acid (DHBT-1) to intermediates that irreversibly inhibit complex I and scavenge glutathione: potential relevance to the pathogenesis of Parkinson's disease.
    Li H; Shen XM; Dryhurst G
    J Neurochem; 1998 Nov; 71(5):2049-62. PubMed ID: 9798930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective and toxic roles of dopamine in Parkinson's disease.
    Segura-Aguilar J; Paris I; Muñoz P; Ferrari E; Zecca L; Zucca FA
    J Neurochem; 2014 Jun; 129(6):898-915. PubMed ID: 24548101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease.
    Berman SB; Hastings TG
    J Neurochem; 1999 Sep; 73(3):1127-37. PubMed ID: 10461904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione depletion resulting in selective mitochondrial complex I inhibition in dopaminergic cells is via an NO-mediated pathway not involving peroxynitrite: implications for Parkinson's disease.
    Hsu M; Srinivas B; Kumar J; Subramanian R; Andersen J
    J Neurochem; 2005 Mar; 92(5):1091-103. PubMed ID: 15715660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are dopamine derivatives implicated in the pathogenesis of Parkinson's disease?
    Bisaglia M; Filograna R; Beltramini M; Bubacco L
    Ageing Res Rev; 2014 Jan; 13():107-14. PubMed ID: 24389159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of 3, 4-dihydroxyacetophenone on Na+, K+ -ATPase activity of injured mitochondria and the oxygen consumption of brain cells of rat.
    Lu XY; Chen WC
    Yao Xue Xue Bao; 2005 Jan; 40(1):13-6. PubMed ID: 15881319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of mitochondria in NO-dependent regulation of Na+, K+ -ATP activity in the rat aorta].
    Akopova OV; Kotsiuruba AV; Kharlamova OM; Korkach IuP; Sahach VF
    Fiziol Zh (1994); 2010; 56(4):76-85. PubMed ID: 20968040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine Oxidation Products as Mitochondrial Endotoxins, a Potential Molecular Mechanism for Preferential Neurodegeneration in Parkinson's Disease.
    Biosa A; Arduini I; Soriano ME; Giorgio V; Bernardi P; Bisaglia M; Bubacco L
    ACS Chem Neurosci; 2018 Nov; 9(11):2849-2858. PubMed ID: 29906101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of vesicular monoamine transporter enhances vulnerability of dopaminergic cells: relevance to Parkinson's disease.
    Choi HJ; Lee SY; Cho Y; Hwang O
    Neurochem Int; 2005 Mar; 46(4):329-35. PubMed ID: 15707697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the small GTPase RhoA in the hypoxia-induced decrease of plasma membrane Na,K-ATPase in A549 cells.
    Dada LA; Novoa E; Lecuona E; Sun H; Sznajder JI
    J Cell Sci; 2007 Jul; 120(Pt 13):2214-22. PubMed ID: 17550967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of mouse cerebral Na+,K(+)-ATPase activity by oxygen free radicals.
    Jamme I; Petit E; Divoux D; Gerbi A; Maixent JM; Nouvelot A
    Neuroreport; 1995 Dec; 7(1):333-7. PubMed ID: 8742483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The ability of cells to adjust to the low oxigen content associated with Na,K-ATPase glutationilation].
    Petrushanko IIu; Simonenko OV; Burnysheva KM; Klimanova EA; Dergousova EA; Mit'kevich VA; Lopina OD; Makarov AA
    Mol Biol (Mosk); 2015; 49(1):175-83. PubMed ID: 25916122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered arachidonic acid metabolism contributes to the failure of dopamine to inhibit Na+,K(+)-ATPase in kidney of spontaneously hypertensive rats.
    Hussain T; Lokhandwala MF
    Clin Exp Hypertens; 1996 Oct; 18(7):963-74. PubMed ID: 8886479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: implications for mitochondrial dysfunction in Parkinson disease.
    Bisaglia M; Soriano ME; Arduini I; Mammi S; Bubacco L
    Biochim Biophys Acta; 2010 Sep; 1802(9):699-706. PubMed ID: 20600874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.